Holen Sie sich die Stockscreener-App
7.1608
2.77%
0.1708
Schlusskurs vom Vortag:
$6.99
Offen:
$7.07
24-Stunden-Volumen:
37,012
Relative Volume:
0.26
Marktkapitalisierung:
$268.26M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
143.22
EPS:
0.05
Netto-Cashflow:
$-8.79M
1W Leistung:
-2.00%
1M Leistung:
-9.07%
6M Leistung:
-9.53%
1J Leistung:
+23.43%
1-Tages-Spanne:
$6.965
$7.21
1-Wochen-Bereich:
$6.815
$7.39
52-Wochen-Spanne:
$4.76
$8.9799
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Firmenname
Lifecore Biomedical Inc
Sektor
Telefon
(952) 368-4300
Adresse
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.16 | 261.89M | 128.45M | 6.54M | -8.79M | 0.05 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.21 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
126.80 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.46 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.52 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
489.64 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | Eingeleitet | William Blair | Outperform |
| 2024-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Herabstufung | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
2026-03-03 | Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical (LFCR) grants 30,000 RSUs to legal chief - Stock Titan
(LFCR) Volatility Zones as Tactical Triggers - Stock Traders Daily
Market Fear: Is Lifecore Biomedical Inc currently under institutional pressureSwing Trade & Smart Money Movement Tracker - baoquankhu1.vn
LFCR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
LFCR Should I Buy - Intellectia AI
LFCR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
2026-02-22 | Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Price-Driven Insight from (LFCR) for Rule-Based Strategy - Stock Traders Daily
Lifecore Biomedical (NASDAQ:LFCR) Shares Up 1.4%Should You Buy? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Lifecore Biomedical to Participate at DCAT Week 2026 - Bitget
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Is Lifecore Biomedical Inc. a top pick in the sectorJuly 2025 Retail & Free Verified High Yield Trade Plans - mfd.ru
Will Lifecore Biomedical Inc. (LDE) stock beat Nasdaq index returnsPrice Action & AI Based Buy and Sell Signals - mfd.ru
Can Lifecore Biomedical Inc. (LDE) stock sustain breakout momentum2025 Trade Ideas & Free Community Consensus Stock Picks - mfd.ru
Aug Reactions: Is Lifecore Biomedical Inc. in a bullish channelTrade Entry Report & Technical Entry and Exit Alerts - mfd.ru
2026-02-12 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Why Lifecore Biomedical Inc. stock remains on watchlists2025 Year in Review & Smart Investment Allocation Insights - mfd.ru
Quarterly Earnings: Will Lifecore Biomedical Inc. stock hit new highs in YEAR2025 Analyst Calls & Weekly Setup with High ROI Potential - mfd.ru
Does Lifecore Biomedical Inc. stock benefit from AI growthTrade Risk Assessment & Capital Efficiency Focused Strategies - mfd.ru
Will Lifecore Biomedical Inc. (LDE) stock see valuation expansionQuarterly Profit Review & Free Expert Verified Stock Movement Alerts - mfd.ru
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - ACCESS Newswire
(LFCR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - ACCESS Newswire
Aug Reactions: What drives Lifecore Biomedical Incs stock priceMarket Volume Report & High Return Stock Watch Alerts - baoquankhu1.vn
Lifecore Biomedical (LFCR) Receives a Buy from Craig-Hallum - The Globe and Mail
2026-02-01 | Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation | NDAQ:LFCR | Press Release - Stockhouse
Can Lifecore Biomedical Inc continue delivering strong returnsJuly 2025 Selloffs & Smart Allocation Stock Tips - baoquankhu1.vn
Market Recap: Is OPTT vulnerable to short sellersRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Portfolio Shifts: Is Lifecore Biomedical Inc a strong candidate for buy and holdIndex Update & Risk Controlled Swing Alerts - baoquankhu1.vn
Notice to Long-Term Shareholders of Lifecore Biomedical, - GlobeNewswire
Lifecore Biomedical Shareholders Seek Reforms After Securities Fraud Settlement - National Today
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
2026-01-29 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect | NDAQ:LFCR | Press Release - Stockhouse
Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: - GlobeNewswire
Is Lifecore Biomedical Inc. a defensive stockTrade Entry Summary & Free Community Supported Trade Ideas - mfd.ru
(LFCR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Lifecore Biomedical (NASDAQ:LFCR) Trading 2.8% HigherHere's Why - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - accessnewswire.com
2026-01-25 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Notice to Long-Term Shareholders of Ibatta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire
Aug PreEarnings: Is Lifecore Biomedical Inc trading at a discountJuly 2025 Decliners & Low Risk Entry Point Tips - baoquankhu1.vn
Notice to Long-Term Shareholders of CoreWeave, Inc. - GlobeNewswire
2026-01-20 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Subdued P/S Might Signal An Opportunity - simplywall.st
Attention Long-Term Shareholders of Ibotta, Inc. (NYSE: - GlobeNewswire
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):